BerandaALTME • EPA
add
TME Pharma NV
Tutup sebelumnya
€0,15
Rentang hari
€0,14 - €0,15
Rentang tahun
€0,11 - €0,44
Kapitalisasi pasar
6,40Â jt EUR
Volume Rata-Rata
636,41Â rb
Rasio P/E
-
Hasil dividen
-
Bursa utama
EPA
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (EUR) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Pendapatan | — | — |
Biaya operasional | 1,37Â jt | -0,51% |
Laba bersih | -1,62Â jt | 11,23% |
Margin laba bersih | — | — |
Penghasilan per saham | — | — |
EBITDA | -1,34Â jt | 0,07% |
Tarif pajak efektif | — | — |
Neraca
Total aset
Total liabilitas
| (EUR) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 2,70Â jt | -10,14% |
Total aset | 2,94Â jt | -15,02% |
Total liabilitas | 1,38Â jt | -62,07% |
Total ekuitas | 1,57 jt | — |
Saham yang beredar | 42,12 jt | — |
Harga terhadap nilai buku | 3,68 | — |
Tingkat pengembalian aset | -116,29% | — |
Tingkat pengembalian modal | -217,64% | — |
Arus Kas
Perubahan kas bersih
| (EUR) | Jun 2024info | Perubahan Y/Y |
|---|---|---|
Laba bersih | -1,62Â jt | 11,23% |
Kas dari operasi | -1,37Â jt | 19,42% |
Kas dari investasi | -4,00Â rb | 57,89% |
Kas dari pembiayaan | 1,60Â jt | 78,88% |
Perubahan kas bersih | 229,00Â rb | 128,17% |
Arus kas bebas | -723,12Â rb | 3,18% |
Tentang
TME Pharma, formerly NOXXON Pharma, is a biotechnology company founded in 1997 in Berlin, Germany which specialises on cancer treatment by targeting the tumor microenvironment. TME Pharma N.V. is listed on Euronext Growth, Paris and is a member of the German Association of Research-Based Pharmaceutical Companies, Verband forschender Arzneimittelhersteller.
TME Pharma develops drugs using technology yielding L-RNA molecules, which are of mirror-image configuration compared to naturally occurring D-RNA molecules. The company calls these agents Spiegelmers, from Spiegel, the German word for "mirror."
The L-RNA are resistant to the natural RNA nuclease enzymes. Wikipedia
Didirikan
1997
Situs
Karyawan
13
